certain of which are beyond IGC Pharma's control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, the Company's failure or inability ...

IGC incorporates by reference its Annual Report on Form 10-K filed with the SEC on June 24, 2024, and on Form 10-Qs filed with the SEC on August 7, 2024, November 12, 2024, and February 14, 2025 ...

IGC Pharma: Fiscal Year 2025 Financial and Operational Highlights - A Year of Transformative Progress in Alzheimer's Innovation Provided by ACCESS Newswire Jun 30, 2025, 6:00:00 AM ...

April 2, 2024 - IGC Pharma released positive interim data from its ongoing Phase 2 CALMA trial for agitation in Alzheimer's disease, providing early validation of IGC-AD1's therapeutic promise.

POTOMAC, MARYLAND / ACCESS Newswire / June 30, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company leveraging AI to develop innovative treatmen ...

IGC incorporates by reference its Annual Report on Form 10-K filed with the SEC on June 24, 2024, and on Form 10-Qs filed with the SEC on August 7, 2024, November 12, 2024, and February 14, 2025 ...

Nepal and India have immense opportunities for trade promotions and in recent years both governments have made efforts to ...

India and Ukraine in their first joint meeting on agriculture discussed key areas of cooperation including seed production, ...

An agreement Hudson’s Bay signed to sell about two dozen leases to a B.C. entrepreneur has encountered a major barrier, new ...

Prime Minister Narendra Modi made a two-day visit to Cyprus on June 15-16, which was the first visit by an Indian Prime Minister in two decades. This visit was part of PM Modi's three-nation visit, ...